Background: Keloids are benign fibroproliferative tumors that extend beyond the original wound. Spontaneous keloids are those that result without a significant history of trauma. There are multiple reported cases in the literature. Objective: This article provides a summary and review of the cases that have been reported with spontaneous keloids and organizes them according to their associated medical conditions. Methods: A literature review was conducted using PubMed and MEDLINE that included all English published cases and case series from May 1955 to February 2018. Results: Spontaneous keloids have been reported mainly in association with syndromes such as Rubinstein-Taybi syndrome, Dubowitz syndrome, Noonan syndrome, Goeminne syndrome, Bethlem myopathy, conjunctivocorneal dystrophy, X-linked recessive polyfibromatosis and a novel X-linked syndrome with flamin A mutation. Furthermore, spontaneous keloids were reported in atopic patients and a couple of patients who are medically healthy. Conclusion: Spontaneous keloids are diagnosed clinically based on the patient’s history, and it is challenging to confirm since they might be triggered by minimal injury or inflammation especially if it is a single lesion. Reported syndromes indicate a genetic possibility in the pathogenesis of spontaneous keloids.

Keloids are benign fibroproliferative tumors that occur as a response to any kind of injury to the skin of susceptible individuals. Keloid tissue extends beyond the margins of the wound, which distinguishes it from hypertrophic scars [1]. Keloids tend to grow symptomless, but still can often cause pain or itching. They have a functional, aesthetic, or psychosocial impact on patients, as highlighted by quality-of-life studies [2]. Individuals of African, Hispanic, or Asian descent appear to be at an increased risk for the development of keloids [3]. Spontaneous keloids, that is, those keloidal lesions that develop without any history of trauma or surgery, are very rare. It is generally believed that they are triggered by microtrauma or minimal cutaneous inflammation in genetically susceptible patients. Their exact etiology is still unknown, although they have been described in multiple conditions discussed below.

Spontaneous keloids have been reported in association with certain genetic abnormalities in multiple reports in the literature (Table 1). In Echeverría et al. [4], a 45-year-old man with Bethlem myopathy was reported to have multiple keloids in the sternal area, on the upper back, and lateral side of his right arm. Furthermore, he had the tendency to develop keloids over the surgical site that had been done for torticollis release [4]. Another report exists of 32 female and 50 male Bethlem myopathy cases who developed spontaneous keloids on both sides of the shoulder [5]. In Rubinstein-Taybi syndrome, a boy was diagnosed at the age of 8 years and at the age of 15 years developed spontaneous eruption of keloids without any trauma on the back, in the presternal area, and over the upper arms [6]. A 25-year-old woman with Rubinstein-Taybi syndrome presented with bilateral spontaneous keloids of the shoulders present for several years [7]. There is another report of 45 Indian females with Rubinstein-Taybi syndrome who at the age of 43 years developed an extensive eruption of keloids on the shoulders, arms, legs, and back [8]. In an analysis of 574 patients with Rubinstein-Taybi syndrome, keloids were observed in 28 individuals: 16 were males and 12 were females; all were white, and ages ranged from 3 to 27 years; 6 of them had spontaneous keloids on the shoulders, upper trunk, and arms while the remaining 22 developed keloids after trauma [9]. Spontaneous keloids have been reported in association with Dubowitz syndrome. A 7-year-old boy with Dubowitz syndrome and atopic dermatitis at the age of 4 experienced a sudden onset of keloids without a preceding trauma on the right temple, right neck and right deltoid, and in the right infraclavicular region [10]. A 6-year-old with Noonan syndrome was found to have a tendency to develop recurrent keloids over his right foot rather than having an eruptive presentation like the cases with the previously mentioned syndrome [11]. Goeminne syndrome has been named in 1967 after Luc Goeminne who reported a novel X-linked syndrome in 3 males of the same family. One 33-year-old male who shared the characteristic of the syndrome of congenital muscular torticollis and cryptorchidism was found to have extensive spontaneous multiple keloids on the chest, back, and arms [12]. A Norwegian family of 3 members – a mother and her 2 sons – with conjunctivocorneal dystrophy reported to have keloidal lesions of the hands and fingers but a history of minimal trauma was stated in the case of the mother [13]. There is also a report of a 40-year-old Australian male with X-linked recessive polyfibromatosis who developed a sudden eruption of keloids on the trunk and the extremities by the age of 20 years. There was a positive personal history of keloids before the eruption and a family history as well [14]. There is a report of a 36-year-old Caucasian and Native American male with a novel X-linked syndrome that is associated with mutation in flamin A (FLNA) and includes cardiac valvular disease with reduction in joint mobility. At the age of 6 years he had a keloid eruption on the thighs, hips, and back. Later in life, he developed a keloid over the surgical insertion site of a pacemaker [15]. We also reported that a syndromic 27-year-old female who has mental retardation along with orbital hypertelorism, a broad nasal bridge, high arched palate, and repaired cleft lip developed sudden widespread extensive keloids over multiple sites of her body [16].

Table 1.

Spontaneous keloids and associated genetic disorder

Spontaneous keloids and associated genetic disorder
Spontaneous keloids and associated genetic disorder

Spontaneous keloids have been reported in atopic patients. A 24-year-old white female known to have asthma, pollen allergy, and contact allergy to nickel developed 4 eruptive keloidal lesions on the back without a history of trauma [17]. Another report describes a 34-year-old woman with severe asthma and chronic idiopathic angioedema who developed 2 keloidal lesions on the back 10 years prior to her presentation that grew in size over time without a trauma [18].

Spontaneous keloid has been reported in patients who are medically healthy. A report describes an 81-year-old male who is medically healthy but developed a single right postauricular spontaneous keloid [19]. There are another report of a 39-year-old man without a medical history who developed a sudden eruption of multiple keloids on the chest [20] and a report of a 21-year-old female who was otherwise healthy with spontaneous keloids on the chest and back [21]. There is also a report of a 63-year-old man after renal transplantation who shortly after the transplantation developed eruptive keloids that continued to increase in size and number and stabilized after a year. A punch biopsy result was consistent with keloids. Additionally, the lesions stained positive for CD68 and factor XIIIa, both of which are correlated with the lesions of nephrogenic systemic fibrosis. However, the patient did not present with the classic clinical presentation of nephrogenic systemic fibrosis, had no history of exposure to gadolinium, and staining for CD34 was negative [22]. In one analysis of 259 Syrian patients with keloids, spontaneous keloids were found in 13.4% mostly on the shoulders and in the presternal region, and there was a significant statistical association between blood group A and spontaneous keloids [23]. Another analysis of 88 Iraqi patients with an incidence of spontaneous keloids in 30 patients (34%) showed that these were mostly single keloid lesions on the upper part of the body [24]. Further reports describe single spontaneous keloids over the nipple of a 56-year-old male and a 79-year-old female [25] as well as 2 sisters aged 21 and 19 years who developed insidious numerous keloids mostly on the chest, back, and arms [26].

The aromatase inhibitor letrozol has been reported to be associated with the development of spontaneous keloid eruption. In Meade et al. [27], the patient had a personal history of keloids, and after 2 months of initiating letrozol she started having new keloidal lesions and aggravation of her existing ones. A discontinuation of letrozol resulted in a stop of getting new keloids [27]. Isotretinoin has also been reported to induce extensive multiple keloidal lesions on the back of a 16-year-old man with nodulocystic acne. The spontaneous eruption began 4 weeks after starting isotretinoin therapy [28]. Another report describes a 27-year-old man with Behçet disease who developed spontaneous multiple keloids on the back around 8 weeks from starting isotretinoin for nodulocystic acne [29].

Spontaneous keloid remains a rare entity and challenging to diagnose. Most of the reported cases were associated with certain syndromes which may raise the question of a genetic link between spontaneous keloids and certain mutations. In addition, it has also been reported in atopic persons and after the use of letrozol and isotretinoin therapy; however, a few reports denied any medical condition which put these cases in a doubtful situation, as there may have been a minor trauma that the patient was unware of, especially if it was only a single keloid.

Spontaneous keloids are associated with genetic disorders and seen in medical conditions or with medications.

The authors have no conflicts of interest that are relevant to the content of this review.

1.
Bayat A, McGrouther DA, Ferguson MW: Skin scarring. BMJ 2003; 326: 88–92.
2.
Bock O, Schmid-Ott G, Malewski P, et al: Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res 2006; 297: 433–438.
3.
Oluwasanmi JO: Keloids in the African. Clin Plast Surg 1974; 1: 179–195.
4.
Echeverría C, Diaz A, Suarez B, et al: Keloids, spontaneous or after minor skin injury: importance of not missing Bethlem myopathy. Acta Derm Venereol 2017; 97: 297–298.
5.
Collins J, Foley AR, Straub V, et al: Spontaneous keloid formation in patients with Bethlem myopathy. Neurology 2012; 79: 2158.
6.
Goodfellow A, Emmerson RW, Calvert HT: Rubinstein-Taybi syndrome and spontaneous keloids. Clin Exp Dermatol 1980; 5: 369–370.
7.
Kurwa AR: Rubinstein-Taybi syndrome and spontaneous keloids. Clin Exp Dermatol 1979; 4: 251–254.
8.
Shilpashree P, Jaiswal AK, Kharge PM: Keloids: an unwanted spontaneity in Rubinstein-Taybi syndrome. Indian J Dermatol 2015; 60: 214.
9.
Siraganian PA, Rubinstein JH, Miller RW: Keloids and neoplasms in the Rubinstein-Taybi syndrome. Med Pediatr Oncol 1989; 17: 485–491.
10.
Paradisi M, Angelo C, Conti G, et al: Dubo-witz syndrome with keloidal lesions. Clin Exp Dermatol 1994; 19: 425–427.
11.
Güleç AT, Karaduman A, Seçkin D: Noonan syndrome: a case with recurrent keloid formation. Cutis 2001; 67: 315–316.
12.
Goeminne L: A new probably X-linked inherited syndrome: congenital muscular torticollis, multiple keloids, cryptorchidism and renal dysplasia. Acta Genet Med Gemellol (Roma) 1968; 17: 439–467.
13.
Haugen OH, Bertelsen T: A new heredi tary conjunctivo-corneal dystrophy associ-ated with dermal keloid formation. Report of a family. Acta Ophthalmol Scand 1998; 76: 461–465.
14.
Ly L, Winship I: X-linked recessive polyfibromatosis manifesting with spontaneous keloid scars and Dupuytren’s contracture. Australas J Dermatol 2012; 53: 148–150.
15.
Atwal PS, Blease S, Braxton A: Novel X-linked syndrome of cardiac valvulopathy, keloid scarring, and reduced joint mobility due to filamin A substitution G1576R. Am J Med Genet A 2016; 170A: 891–895.
16.
Jfri A, Rajeh N, Karkashan E: A case of multiple spontaneous keloid scars. Case Rep Dermatol 2015; 7: 156–160.
17.
Oittinen HA, O’Shaughnessy M: Multiple nonsyndromic spontaneous keloids in allergic disease. Plast Reconstr Surg 2007; 119: 762–763.
18.
McCabe J, Blades Z, McGrath EE: A spontaneous skin lesion. CMAJ 2008; 179: 1297–1299.
19.
Monarca C, Maruccia M, Palumbo F: A rare case of postauricular spontaneous keloid in an elderly patient. In Vivo 2012; 26: 173–175.
20.
Alonso PE, Rioja LF: Spontaneous resolution of a keloid. Plast Reconstr Surg 2011; 128: 98e–99e.
21.
Kerfant N, Gasnier P, Boloorchi A: Spontaneous keloids: about a rare case. Ann Chir Plast Esthet 2011; 56: 339–341.
22.
Bremmer M, Deng A, Martin DB: Spontaneous eruptive keloid-like cutaneous lesions in a renal transplant patient: a form of nephrogenic systemic fibrosis? J Dermatolog Treat 2009; 20: 63–66.
23.
Shaheen A, Khaddam J, Kesh F: Risk factors of keloids in Syrians. BMC Dermatol 2016; 16: 13.
24.
Sharquie KE, Al-Dhalimi MA: Keloid in Iraqi patients: a clinicohistopathologic study. Dermatol Surg 2003; 29: 847–851.
25.
Finlay GH, Stoughton RB: Spontaneous keloid with unusual histologic features. AMA Arch Derm 1955; 71: 599–601.
26.
Mandal A, Imran D, Rao GS: Spontaneous keloids in siblings. Ir Med J 2004; 97: 250–251.
27.
Meade C, Smith S, Makhzoumi Z: Eruptive keloids associated with aromatase inhibitor therapy. JAAD Case Rep 2015; 1: 112–113.
28.
Ginarte M, Peteiro C, Toribio J: Keloid formation induced by isotretinoin therapy. Int J Dermatol 1999; 38: 228–229.
29.
Dogan G: Possible isotretinoin-induced keloids in a patient with Behcet’s disease. Clin Exp Dermatol 2006; 31: 535–537.

Spontaneous keloids are associated with genetic disorders and seen in medical conditions or with medications.

Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.